Renee P. Tannenbaum's Insider Trades & SAST Disclosures
Renee P. Tannenbaum's most recent trade in ANI Pharmaceuticals Inc was a trade of 4,336 Common Stock done . Disclosure was reported to the exchange on May 22, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Renee P. Tannenbaum.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | Renee P. Tannenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 4,336 | 26,957 (0%) | 0% | 0 | Common Stock | |
| Cardiff Oncology Inc | Renee P. Tannenbaum | Director | Purchase of securities on an exchange or from another person at price $ 3.42 per share. | 12 Dec 2024 | 10,000 | 20,000 (0%) | 0% | 3.4 | 34,224 | Common Stock |
| Cardiff Oncology Inc | Renee P. Tannenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 29,700 | 128,201 | - | - | Stock Options | |
| ANI Pharmaceuticals Inc | Renee P. Tannenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,410 | 22,621 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Renee P. Tannenbaum | Director | Sale of securities on an exchange or to another person at price $ 63.87 per share. | 16 May 2024 | 2,000 | 18,211 (0%) | 0% | 63.9 | 127,740 | Common Stock |
| Cardiff Oncology Inc | Renee P. Tannenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 27,700 | 98,501 | - | - | Stock Options | |
| ANI Pharmaceuticals Inc | Renee P. Tannenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 6,865 | 20,211 (0%) | 0% | 0 | Common Stock | |
| Cardiff Oncology Inc | Renee P. Tannenbaum | Director | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 15 Sep 2022 | 6,400 | 6,400 (0%) | 0% | 1.7 | 10,976 | Common Stock |
| Cardiff Oncology Inc | Renee P. Tannenbaum | Director | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 15 Sep 2022 | 3,600 | 10,000 (0%) | 0% | 1.7 | 6,192 | Common Stock |
| ANI Pharmaceuticals Inc | Renee P. Tannenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2022 | 13,346 | 13,346 (0%) | 0% | 0 | Common Stock | |
| Cardiff Oncology Inc | Renee P. Tannenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 26,800 | 70,801 | - | - | Stock Options |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges